FdaApplication

ANDA 077205

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCHARTWELL MOLECULAR HOLDINGS LLC
application_typeANDA
approval_date2012-11-14

Products (3)

ProductActive ingredientStrengthDosage form
IRBESARTANIRBESARTAN150MGTABLET;ORAL
IRBESARTANIRBESARTAN300MGTABLET;ORAL
IRBESARTANIRBESARTAN75MGTABLET;ORAL

3 products